Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 9.226
Immunology ; 162(1): 1-2, 2021 01.
Artículo en Inglés | MEDLINE | ID: mdl-33305861


2020 was a year unlike any other for Immunology. Through the SARS-CoV-2 pandemic, with fantastic support from the global immunology community, we worked together to reach new heights. Here, we look back at some of the highlights for Immunology in a challenging and memorable year.

Alergia e Inmunología/tendencias , Investigación Biomédica/tendencias , Publicaciones Periódicas como Asunto/tendencias , Políticas Editoriales , Humanos , Difusión de la Información , Factor de Impacto de la Revista
Pediatr. aten. prim ; 22(88): e217-e222, oct.-dic. 2020. tab, graf
Artículo en Español | IBECS | ID: ibc-196408


Las prepublicaciones (preprints) han crecido notablemente en los últimos meses, impulsadas por las exigencias de la pandemia de COVID-19. Aportan soluciones a algunas brechas de las publicaciones tradicionales con revisión por pares, pero no están libres de efectos no deseados. Se hace una revisión del tema, las ventajas e inconvenientes y retos futuros

Pre-publications (preprints) have grown notably in recent months, driven by the demands of the COVID-19 pandemic. They provide solutions to some gaps in traditional peer-reviewed publications, but they are not without unwanted effects. A review is made of the subject, the advantages and disadvantages and future challenges

Humanos , Publicaciones Periódicas como Asunto , Políticas Editoriales , Infecciones por Coronavirus , Neumonía Viral , Pandemias , Comunicación y Divulgación Científica
Clin Sci (Lond) ; 134(24): 3233-3235, 2020 12 23.
Artículo en Inglés | MEDLINE | ID: mdl-33313696


As this extraordinary year, blemished by COVID-19, comes to an end, I look back as Editor-in-Chief to the many great successes and new initiatives of Clinical Science. Despite the challenges we all faced during 2020, our journal has remained strong and vibrant. While we have all adapted to new working conditions, with life very different to what it was pre-COVID-19, the one thing that remains intact and secure is the communication of scientific discoveries through peer-reviewed journals. I am delighted to share with you some of the many achievements of our journal over the past year and to highlight some exciting new activities planned for 2021.

Investigación Biomédica/normas , Políticas Editoriales , Publicaciones Periódicas como Asunto/normas , Investigación Biomédica/estadística & datos numéricos , Investigación Biomédica/tendencias , /inmunología , /administración & dosificación , Predicción , Humanos , Pandemias/prevención & control , Publicaciones Periódicas como Asunto/estadística & datos numéricos , Publicaciones Periódicas como Asunto/tendencias , /fisiología
Adv Chronic Kidney Dis ; 27(5): 418-426, 2020 09.
Artículo en Inglés | MEDLINE | ID: mdl-33308508


The coronavirus disease 2019 (COVID-19) pandemic has spread exponentially throughout the world in a short period, aided by our hyperconnected world including global trade and travel. Unlike previous pandemics, the pace of the spread of the virus has been matched by the pace of publications, not just in traditional journals, but also in preprint servers. Not all publication findings are true, and sifting through the firehose of data has been challenging to peer reviewers, editors, as well as to consumers of the literature, that is, scientists, healthcare workers, and the general public. There has been an equally exponential rise in the public discussion on social media. Rather than decry the pace of change, we suggest the nephrology community should embrace it, making deposition of research into preprint servers the default, encouraging prepublication peer review more widely of such preprint studies, and harnessing social media tools to make these actions easier and seamless.

Nefrología , Revisión de la Investigación por Pares , Preimpresos como Asunto , Blogging , Políticas Editoriales , Humanos , Publicación de Acceso Abierto , Publicaciones Periódicas como Asunto , Medios de Comunicación Sociales
PLoS One ; 15(10): e0239598, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-33002031


Scientific claims in biomedical research are typically derived from statistical analyses. However, misuse or misunderstanding of statistical procedures and results permeate the biomedical literature, affecting the validity of those claims. One approach journals have taken to address this issue is to enlist expert statistical reviewers. How many journals do this, how statistical review is incorporated, and how its value is perceived by editors is of interest. Here we report an expanded version of a survey conducted more than 20 years ago by Goodman and colleagues (1998) with the intention of characterizing contemporary statistical review policies at leading biomedical journals. We received eligible responses from 107 of 364 (28%) journals surveyed, across 57 fields, mostly from editors in chief. 34% (36/107) rarely or never use specialized statistical review, 34% (36/107) used it for 10-50% of their articles and 23% used it for all articles. These numbers have changed little since 1998 in spite of dramatically increased concern about research validity. The vast majority of editors regarded statistical review as having substantial incremental value beyond regular peer review and expressed comparatively little concern about the potential increase in reviewing time, cost, and difficulty identifying suitable statistical reviewers. Improved statistical education of researchers and different ways of employing statistical expertise are needed. Several proposals are discussed.

Publicaciones Periódicas como Asunto , Estadística como Asunto , Investigación Biomédica/métodos , Investigación Biomédica/normas , Investigación Biomédica/estadística & datos numéricos , Interpretación Estadística de Datos , Políticas Editoriales , Humanos , Revisión por Pares , Publicaciones Periódicas como Asunto/normas , Publicaciones Periódicas como Asunto/estadística & datos numéricos , Reproducibilidad de los Resultados , Estadística como Asunto/métodos , Estadística como Asunto/normas , Encuestas y Cuestionarios
Int J Esthet Dent ; 15(4): 369-371, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-33089253
Med Lav ; 111(4): 247-248, 2020 Aug 31.
Artículo en Inglés | MEDLINE | ID: mdl-32869762


At the time of writing, the COVID-19 pandemic is assuming a distinct shape as do healthcare systems around the world. Some countries resisted to the tsunami and are now re-opening their industrial and commercial activities while re-organizing to face a possible new wave. Others are still struggling not to be overwhelmed by the most significant public health challenge of the last century. In Italy, after a strict lockdown, almost all activities are re-opening, trying to navigate between Scylla (epidemics and its economic consequences) and Cariddi (economic recession and its adverse health effects) bearing in mind that there is collinearity between the circulation of money and spreading of the virus and that there is a serious risk of a vicious spiral which could affect the society. The prolonged lockdown deemed to prevent the spreading of the virus also reduced the circulation of money, and hence tax revenues, thus it will ultimately result in fewer finances available for social security and Public Health (3). The main political issue will then be the definition of a right point of equilibrium between risks and benefits, between action and precaution. As scientists, we are called to distinguish between what we know and what is unknown, between data and opinions, between facts and beliefs. [...].

Infecciones por Coronavirus/epidemiología , Neumonía Viral/epidemiología , Comunicación por Videocoferencia , Betacoronavirus , Políticas Editoriales , Humanos , Italia , Pandemias